Ruta Brazauskas, PhD

Associate Professor

Locations

Biostatistics

Contact Information

Education

PhD, Biostatistics, Medical College of Wisconsin, Milwaukee, WI, 2003
MS, Statistics, University of Texas at Dallas, Richardson, TX, 1999
BS, Applied Mathematics, Vilnius University, Lithuania, 1992

Research Experience

Survival Analysis

Research Interests

Dr. Ruta Brazauskas joined the Division of Biostatistics in June 2008. Dr. Brazauskas’ research interests include survival analysis and competing risks. Most recent methodological work on the issues of paired studies in survival analysis was funded by the CTSA supplemental grant awarded to a group of faculty members at the Division. Her collaborative work is mostly focused on the outcomes of bone marrow transplantation (BMT) and in particular long-tern effects of the BMT. Dr. Brazauskas is the lead statistician of the Late Effects Working Committee and Health Policy Working Committee at the Center for International Bone Marrow Transplant Research. Her other collaborators include MCW physicians from various departments as well as researchers in the area of public health. In 2012, Dr. Brazauskas received the Graduate Student Association's Teacher of the Year Award for her exceptional teaching in Biostatistics.

Curriculum Vitae

Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial.

(Brazauskas R, Flynn K, Krishnan A, Landau H, Giralt S, Pasquini MC, Stadtmauer EA, D'Souza A.) Br J Haematol. 2024 Apr;204(4):1429-1438 PMID: 38348544 PMCID: PMC11006567 SCOPUS ID: 2-s2.0-85185482209 02/13/2024
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients.

(Zinter MS, Brazauskas R, Strom J, Chen S, Bo-Subait S, Sharma A, Beitinjaneh A, Dimitrova D, Guilcher G, Preussler J, Myers K, Bhatt NS, Ringden O, Hematti P, Hayashi RJ, Patel S, De Oliveira SN, Rotz S, Badawy SM, Nishihori T, Buchbinder D, Hamilton B, Savani B, Schoemans H, Sorror M, Winestone L, Duncan C, Phelan R, Dvorak CC.) Blood Adv. 2024 Feb 27;8(4):1002-1017 PMID: 38127268 PMCID: PMC10879681 SCOPUS ID: 2-s2.0-85187724652 12/21/2023
Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients.

(Shaw BE, Flynn KE, He N, Cusatis R, D'Souza A, Hamilton BK, Horowitz MM, Mattila D, Phelan R, Lee SJ, Brazauskas R.) Cancer. 2024 Jan 10 PMID: 38198511 SCOPUS ID: 2-s2.0-85181878144 01/10/2024
Corrigendum to “Endpoint selection and evaluation in hematology studies” [Best Pract Res Clin Haematol 36 (2023) 101479] (Best Practice & Research Clinical Haematology (2023) 36(3), (S1521692623000403), (10.1016/j.beha.2023.101479))

(Brazauskas R, Eapen M, Wang T.) Best Practice and Research: Clinical Haematology. March 2024;37(1) SCOPUS ID: 2-s2.0-85185562266 03/01/2024
Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.

(Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Badawy SM, Bhatt N, Bhatt VR, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Hashmi S, Hematti P, Hossain NM, Inamoto Y, Lekakis LJ, Sharma A, Solomon S, Lee SJ, Couriel DR.) Transplant Cell Ther. 2024 Jan;30(1):97.e1-97.e14 PMID: 37844687 PMCID: PMC10842798 SCOPUS ID: 2-s2.0-85176587436 10/17/2023
Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis.

(Taylor MR, Cole SW, Strom J, Brazauskas R, Baker KS, Phelan R, Buchbinder D, Hamilton B, Schoemans H, Shaw BE, Sharma A, Bhatt NS, Badawy SM, Winestone LE, Preussler JM, Mayo S, Jamani K, Nishihori T, Lee MA, Knight JM.) Blood Adv. 2023 Nov 28;7(22):6830-6838 PMID: 37773924 PMCID: PMC10679811 SCOPUS ID: 2-s2.0-85178332888 09/29/2023
Video Education in Early Pregnancy and Parent Knowledge of Neonatal Resuscitation Options: A Secondary Analysis of a Randomized Clinical Trial.

(McDonnell SM, Flynn KE, McIntosh JJ, Brazauskas R, Kim UO, Ahamed SI, Basir MA.) JAMA Netw Open. 2023 Nov 01;6(11):e2344645 PMID: 38010656 PMCID: PMC10682831 SCOPUS ID: 2-s2.0-85178082450 11/27/2023
Lack of Association of Initial Vasopressor Dosing with Survival and Cardiac Re-Arrest Likelihood After Return of Spontaneous Circulation.

(Sharpe AR, Richardson K, Stanton M, Dang C, Feih J, Brazauskas R, Teng BQ, Feldman R.) J Emerg Med. 2023 Sep;65(3):e209-e220 PMID: 37635036 SCOPUS ID: 2-s2.0-85169781378 08/28/2023
Endpoint selection and evaluation in hematology studies.

(Brazauskas R, Eapen M, Wang T.) Best Pract Res Clin Haematol. 2023 Sep;36(3):101479 PMID: 37611997 PMCID: PMC10979628 SCOPUS ID: 2-s2.0-85161313534 08/24/2023
Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients.

(Zinter MS, Brazauskas R, Strom J, Chen S, Bo-Subait S, Sharma A, Beitinjaneh A, Dimitrova D, Guilcher G, Preussler J, Myers K, Bhatt NS, Ringden O, Hematti P, Hayashi RJ, Patel S, De Oliveira SN, Rotz S, Badawy SM, Nishihori T, Buchbinder D, Hamilton B, Savani B, Schoemans H, Sorror M, Winestone L, Duncan C, Phelan R, Dvorak CC.) medRxiv. 2023 Aug 05 PMID: 37577706 PMCID: PMC10418579 08/14/2023
Smartphone-Based Video Antenatal Preterm Birth Education: The Preemie Prep for Parents Randomized Clinical Trial.

(Flynn KE, McDonnell SM, Brazauskas R, Ahamed SI, McIntosh JJ, Pitt MB, Pizur-Barnekow K, Kim UO, Kruper A, Leuthner SR, Basir MA.) JAMA Pediatr. 2023 Jul 31;177(9):921-9 PMID: 37523163 PMCID: PMC10481234 SCOPUS ID: 2-s2.0-85172220214 07/31/2023
Endpoint selection and evaluation in hematology studies

(Brazauskas R, Eapen M, Wang T.) Best Practice and Research: Clinical Haematology. September 2023;36(3) SCOPUS ID: 2-s2.0-85161313534 09/01/2023